Published in J Am Soc Nephrol on February 15, 2006
Benefits and harms of statin therapy for persons with chronic kidney disease: a systematic review and meta-analysis. Ann Intern Med (2012) 3.62
Sensitivity of billing claims for cardiovascular disease events among kidney transplant recipients. Clin J Am Soc Nephrol (2009) 2.17
Variations in the risk for cerebrovascular events after kidney transplant compared with experience on the waiting list and after graft failure. Clin J Am Soc Nephrol (2008) 1.02
Obesity and cardiac risk after kidney transplantation: experience at one center and comprehensive literature review. Transplantation (2008) 0.96
Cardiovascular risk assessment among potential kidney transplant candidates: approaches and controversies. Am J Kidney Dis (2009) 0.94
Serum fetuin-A levels are associated with vascular calcifications and predict cardiovascular events in renal transplant recipients. Clin J Am Soc Nephrol (2011) 0.91
Cardiac evaluation before kidney transplantation: a practice patterns analysis in Medicare-insured dialysis patients. Clin J Am Soc Nephrol (2008) 0.90
Cardiovascular disease in transplant recipients: current and future treatment strategies. Clin J Am Soc Nephrol (2008) 0.86
Cardiovascular diseases after kidney transplantation in Korea. J Korean Med Sci (2010) 0.85
Design considerations and feasibility for a clinical trial to examine coronary screening before kidney transplantation (COST). Am J Kidney Dis (2011) 0.83
CD28 family and chronic rejection: "to belatacept...And beyond!". J Transplant (2012) 0.82
Primary care of the renal transplant patient. J Gen Intern Med (2010) 0.80
Calcium and osteoprotegerin levels predict the progression of the abdominal aortic calcifications after kidney transplantation. Transplantation (2013) 0.79
Incidence of cardiovascular events after kidney transplantation and cardiovascular risk scores: study protocol. BMC Cardiovasc Disord (2011) 0.78
A Comparison of Different Algorithms for the Assessment of Cardiovascular Risk in Patients at Waiting List for Kidney Transplantation. PLoS One (2016) 0.75
Diagnosis and Management of Cardiovascular Disease in Advanced and End-Stage Renal Disease. J Am Heart Assoc (2016) 0.75
Cardiac and vascular changes with kidney transplantation. Indian J Nephrol (2016) 0.75
ST-Elevation Myocardial Infarction 33 Days after Lung Transplant in a Patient with Non-Significant CAD before Transplantation: A Case Report. J Clin Diagn Res (2016) 0.75
Serum osteoprotegerin is associated with pulse pressure in kidney transplant recipients. Sci Rep (2015) 0.75
Predictors and prognostic implications of major adverse cardiovascular events after renal transplant: 10 years outcomes in 321 patients. Int J Angiol (2014) 0.75
Updating the Beers criteria for potentially inappropriate medication use in older adults: results of a US consensus panel of experts. Arch Intern Med (2003) 13.47
Cancer after kidney transplantation in the United States. Am J Transplant (2004) 5.08
Spectrum of cancer risk among US solid organ transplant recipients. JAMA (2011) 4.99
Diabetes mellitus after kidney transplantation in the United States. Am J Transplant (2003) 4.39
The differential impact of risk factors on mortality in hemodialysis and peritoneal dialysis. Kidney Int (2004) 2.63
Scientific Registry of Transplant Recipients: collecting, analyzing, and reporting data on transplantation in the United States. Transplant Rev (Orlando) (2013) 2.19
Preemptive kidney transplantation: the advantage and the advantaged. J Am Soc Nephrol (2002) 2.19
Propensity-matched mortality comparison of incident hemodialysis and peritoneal dialysis patients. J Am Soc Nephrol (2010) 2.08
Septicemia in the United States dialysis population, 1991 to 1999. J Am Soc Nephrol (2004) 1.70
A simple tool to predict outcomes after kidney transplant. Am J Kidney Dis (2010) 1.63
Hypertension after kidney transplantation. Am J Kidney Dis (2004) 1.59
Kidney function and risk triage in adults: threshold values and hierarchical importance. Kidney Int (2010) 1.57
Cardiovascular disease medications after renal transplantation: results from the Patient Outcomes in Renal Transplantation study. Transplantation (2011) 1.56
Lymphoproliferative disorders after adult kidney transplant: epidemiology and comparison of registry report with claims-based diagnoses. Am J Kidney Dis (2011) 1.53
Does cadaveric donor renal transplantation ever provide better outcomes than live-donor renal transplantation? Transplantation (2003) 1.51
Cost Implications of New National Allocation Policy for Deceased Donor Kidneys in the United States. Transplantation (2016) 1.42
Patients value metastatic cancer therapy more highly than is typically shown through traditional estimates. Health Aff (Millwood) (2012) 1.38
Influenza vaccine delivery and effectiveness in end-stage renal disease. Kidney Int (2003) 1.36
Cystatin C levels in U.S. adults, 1988-1994 versus 1999-2002: NHANES. Clin J Am Soc Nephrol (2009) 1.31
Depressive disorder in renal transplantation: an analysis of Medicare claims. Am J Kidney Dis (2008) 1.22
Liver sharing and organ procurement organization performance. Liver Transpl (2015) 1.21
Delayed hepatocellular carcinoma model for end-stage liver disease exception score improves disparity in access to liver transplant in the United States. Hepatology (2015) 1.20
The relationship between kidney function and long-term graft survival after kidney transplant. Am J Kidney Dis (2011) 1.09
Inadequate donor size in cadaver kidney transplantation. J Am Soc Nephrol (2002) 1.07
The role of procurement biopsies in acceptance decisions for kidneys retrieved for transplant. Clin J Am Soc Nephrol (2014) 1.02
How cancer patients value hope and the implications for cost-effectiveness assessments of high-cost cancer therapies. Health Aff (Millwood) (2012) 1.01
Comparison and survival of hemodialysis and peritoneal dialysis in the elderly. Semin Dial (2002) 0.99
Cardiac evaluation before kidney transplantation: a practice patterns analysis in Medicare-insured dialysis patients. Clin J Am Soc Nephrol (2008) 0.90
Chronic kidney disease awareness, screening and prevention: rationale for the design of a public education program. Nephrology (Carlton) (2010) 0.89
Clinical diagnosis of metabolic syndrome: predicting new-onset diabetes, coronary heart disease, and allograft failure late after kidney transplant. Transpl Int (2012) 0.88
The effects of rheumatoid arthritis on labor force participation, work performance, and healthcare costs in two workplace samples. J Occup Environ Med (2008) 0.88
The impact of kidney transplantation on heart failure risk varies with candidate body mass index. Am Heart J (2009) 0.86
Who is caring for kidney transplant patients? Variation by region, transplant center, and patient characteristics. Am J Nephrol (2009) 0.86
Design considerations and feasibility for a clinical trial to examine coronary screening before kidney transplantation (COST). Am J Kidney Dis (2011) 0.83
A randomized study to decrease the use of potentially inappropriate medications among community-dwelling older adults in a southeastern managed care organization. Am J Manag Care (2004) 0.83
Variation in Cost and Quality in Kidney Transplantation. Transplantation (2015) 0.80
Blood transfusions in kidney transplant candidates are common and associated with adverse outcomes. Clin Transplant (2011) 0.78
Predicting Outcomes on the Liver Transplant Waiting List in the United States: Accounting for Large Regional Variation in Organ Availability and Priority Allocation Points. Transplantation (2016) 0.75
Metformin use in kidney transplant recipients in the United States: an observational study. Am J Nephrol (2015) 0.75
Beyond "Median Waiting Time": Development and Validation of a Competing Risk Model to Predict Outcomes on the Kidney Transplant Waiting List. Transplantation (2016) 0.75